SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
1-Year Return
5.3%
This Quarter Return
+13.1%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$273M
AUM Growth
+$58.5M
(+27%)
Cap. Flow
+$37.2M
Cap. Flow
% of AUM
13.63%
Top 10 Holdings %
Top 10 Hldgs %
31.23%
Holding
76
New
17
Increased
24
Reduced
16
Closed
9
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$9.26M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$7.3M |
| 3 |
Gilead Sciences
GILD
|
$6.37M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$4.91M |
| 5 |
AbbVie
ABBV
|
$4.35M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$6.73M |
| 2 |
Zimmer Biomet
ZBH
|
$4.88M |
| 3 |
Bristol-Myers Squibb
BMY
|
$4.21M |
| 4 |
Tenet Healthcare
THC
|
$3.99M |
| 5 |
AstraZeneca
AZN
|
$3.89M |
Sector Composition
| 1 | Healthcare | 87.53% |
| 2 | Financials | 2.5% |
| 3 | Energy | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
51
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.87M | 0.69% |
20,000
| – | – |
|
|
KITE
52
DELISTED
Kite Pharma, Inc.
KITE
| $1.87M | 0.68% |
18,000
| – | – |
|
|
DPLO
53
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.78M | 0.65% |
120,000
+19,000
| +19% | +$281K |
|
54
Puma Biotechnology
PBYI
$251M
| $1.75M | 0.64% |
20,000
-10,000
| -33% | -$874K |
|
55
Illumina
ILMN
$15.3B
| $1.74M | 0.64% |
10,280
| – | – |
|
|
PTLA
56
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.69M | 0.62% |
+30,000
| New | +$1.69M |
|
|
LOXO
57
DELISTED
Loxo Oncology, Inc
LOXO
| $1.64M | 0.6% |
+20,500
| New | +$1.64M |
|
|
SAGE
58
DELISTED
Sage Therapeutics
SAGE
| $1.59M | 0.58% |
20,000
| – | – |
|
|
BCR
59
DELISTED
CR Bard Inc.
BCR
| $1.58M | 0.58% |
5,000
-5,000
| -50% | -$1.58M |
|
|
BLUE
60
DELISTED
bluebird bio
BLUE
| $1.58M | 0.58% |
1,158
+85
| +8% | +$116K |
|
61
Acadia Pharmaceuticals
ACAD
$4.32B
| $1.53M | 0.56% |
55,000
-10,000
| -15% | -$279K |
|
|
KND
62
DELISTED
Kindred Healthcare
KND
| $1.46M | 0.53% |
125,000
+27,785
| +29% | +$324K |
|
|
SGEN
63
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.29M | 0.47% |
25,000
+10,000
| +67% | +$518K |
|
64
Neurocrine Biosciences
NBIX
$13.7B
| $920K | 0.34% |
20,000
-5,000
| -20% | -$230K |
|
|
65
AstraZeneca
AZN
$254B
| – | – |
-125,000
| Closed | -$3.89M |
|
|
66
Bristol-Myers Squibb
BMY
$95B
| – | – |
-77,400
| Closed | -$4.21M |
|
|
67
Eli Lilly
LLY
$668B
| – | – |
-80,000
| Closed | -$6.73M |
|
68
ResMed
RMD
$40B
| – | – |
-21,200
| Closed | -$1.53M |
|
69
Teva Pharmaceuticals
TEVA
$21.3B
| – | – |
-50,000
| Closed | -$1.61M |
|
|
70
Tenet Healthcare
THC
$16.9B
| – | – |
-225,000
| Closed | -$3.99M |
|
71
Viatris
VTRS
$12.1B
| – | – |
-60,000
| Closed | -$2.34M |
|
|
72
Zimmer Biomet
ZBH
$20.9B
| – | – |
-41,200
| Closed | -$4.88M |
|
|
PRXL
73
DELISTED
Parexel International Corp
PRXL
| – | – |
-35,000
| Closed | -$2.21M |
|